OrthoPediatrics Corp. (KIDS)

NASDAQ: KIDS · IEX Real-Time Price · USD
56.67
+1.61 (2.92%)
Aug 15, 2022 4:00 PM EDT - Market closed
2.92%
Market Cap 1.15B
Revenue (ttm) 106.24M
Net Income (ttm) -11.56M
Shares Out 20.28M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 153,163
Open 54.60
Previous Close 55.06
Day's Range 53.90 - 56.67
52-Week Range 36.71 - 73.91
Beta 0.88
Analysts Buy
Price Target 60.69 (+7.1%)
Earnings Date Aug 3, 2022

About KIDS

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking can... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Oct 12, 2017
CEO Mark Throdahl
Employees 133
Stock Exchange NASDAQ
Ticker Symbol KIDS
Full Company Profile

Financial Performance

In 2021, KIDS's revenue was $98.05 million, an increase of 37.95% compared to the previous year's $71.08 million. Losses were -$16.26 million, -50.64% less than in 2020.

Financial Statements

Analyst Forecast

According to 13 analysts, the average rating for KIDS stock is "Buy." The 12-month stock price forecast is 60.69, which is an increase of 7.09% from the latest price.

Price Target
$60.69
(7.09% upside)
Analyst Consensus: Buy
Stock Forecasts

News

OrthoPediatrics Corp. Announces Closing of its Public Offering of Common Stock and Pre-Funded Warrants and Full Exerc...

WARSAW, Ind., Aug. 15, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...

OrthoPediatrics Corp. Announces Proposed Offering of Common Stock and Pre-Funded Warrants

WARSAW, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...

OrthoPediatrics (KIDS) Reports Q2 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of -13.33% and 0.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

OrthoPediatrics Corp. Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

Second Quarter 2022 Record Revenue Increased 23% Year-over-Year Second Quarter 2022 Record Adjusted EBITDA of $2.1 million

2022 Roundtable: Our Favorite Picks Right Now

Here's why we like Novavax, Orthopediatrics, and Pliant Therapeutics.

Other symbols: NVAXPLRX

OrthoPediatrics Corp. to Report Second Quarter 2022 Financial Results on August 4, 2022

WARSAW, Ind., July 21, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...

OrthoPediatrics Corp. Completes Acquisition of Pega Medical

WARSAW, Ind., July 05, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...

Buy the Dip on These 3 Healthcare Stocks

Here's why our roundtable likes Vir Biotechnology, OrthoPediatrics, and Vertex Pharmaceuticals.

Other symbols: VIRVRTX

OrthoPediatrics Corp. Announces Deal to Acquire Pega Medical

Expands portfolio of trauma and deformity systems for pediatric orthopedics, including the Fassier-Duval Telescopic IM System™ Expands portfolio of trauma and deformity systems for pediatric orthopedics...

OrthoPediatrics to Participate in The JMP Securities Life Sciences Conference

WARSAW, Ind., May 24, 2022 (GLOBE NEWSWIRE) --  OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...

OrthoPediatrics (KIDS) Reports Q1 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 0% and 3.15%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

OrthoPediatrics Corp. Reports First Quarter 2022 Financial Results and Increases 2022 Revenue Guidance

First Quarter 2022 Revenue Increased 9% Year-over-Year First Quarter 2022 Revenue Increased 9% Year-over-Year

OrthoPediatrics Corp. to Report First Quarter 2022 Financial Results on May 5, 2022

WARSAW, Ind., April 18, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today ...

3 Healthcare Stocks to Buy and Hold for the Next 10 Years

These companies have a history of creating shareholder value -- and still have plenty of room for growth.

Other symbols: OMCLPEN

OrthoPediatrics Corp. Announces Acquisition of MD Orthopaedics

Expands portfolio with a patented, non-operative solution for the treatment of clubfoot Expands portfolio with a patented, non-operative solution for the treatment of clubfoot

OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates

OrthoPediatrics (KIDS) delivered earnings and revenue surprises of 17.24% and 0.13%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

OrthoPediatrics Corp. Reports Fourth Quarter and Record Full Year 2021 Financial Results

Fourth Quarter 2021 Revenue Increased 31% Year-over-Year 2021 Revenue Increased 38% Year-over-Year

OrthoPediatrics Corp. Named One of the 2022 Best Places to Work in Indiana

WARSAW, Ind., Feb. 25, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, ...

OrthoPediatrics (KIDS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

OrthoPediatrics (KIDS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

OrthoPediatrics Corp. Celebrates 1,000th Case with FIREFLY® Pedicle Screw Navigation Guides

Company's partnership with Mighty Oak Medical for 3D printed, patient-specific technology continues advancing pediatric scoliosis treatment Company's partnership with Mighty Oak Medical for 3D printed, ...

OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022

WARSAW, Ind., Feb. 01, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today t...

OrthoPediatrics Announces Preliminary Unaudited Revenue for the Fourth Quarter & Full-Year 2021

WARSAW, Ind., Jan. 10, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, ...

Telos Partners LLC Welcomes Industry Veteran Scott Day as Senior VP and General Manager to Accelerate Growth Strategy

WARSAW, Ind.--(BUSINESS WIRE)-- #MDR--Telos Partners LLC, a subsidiary of OrthoPediatrics Corporation (NASDAQ: KIDS), specializing in the delivery of regulatory, reimbursement, and clinician adoption an...

3 Last-Minute Healthcare Stocking Stuffers

Here are three stocks sure to pique the interest of that special someone.

Other symbols: ISRGPFE

OrthoPediatrics Corp. Continued Double-Diamond Support of International Pediatric Orthopaedic Symposium (IPOS)

WARSAW, Ind., Dec. 13, 2021 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced its continued support as a ...